TUMOR-CELL MEMBRANE AS A POTENTIAL TARGET FOR METHYL-BETA-CYCLODEXTRIN

Citation
Py. Grosse et al., TUMOR-CELL MEMBRANE AS A POTENTIAL TARGET FOR METHYL-BETA-CYCLODEXTRIN, Anticancer research, 18(1A), 1998, pp. 379-384
Citations number
17
Categorie Soggetti
Oncology
Journal title
ISSN journal
02507005
Volume
18
Issue
1A
Year of publication
1998
Pages
379 - 384
Database
ISI
SICI code
0250-7005(1998)18:1A<379:TMAAPT>2.0.ZU;2-V
Abstract
The purpose of this work was to determine the role of methyl-beta-cycl odextrin (MEBCD) in combination with doxorubicin (DOX) on DOX intracel lular accumulation and efflux, in comparison to vempamil in a sensitiv e parental and multidrug-resistant human cancer cell line (HL-60 S and HL-60 R). Moreover, cell membrane and nuclear modifications induced b y MEBCD were investigated. At concentration of 10 mu mol for 10(6) cel ls, MEBCD combined with doxorubicin (DOX), was able to significantly e nhance the intracellular concentration of DOX in HL-60 S and HL-60 R c ell lines during the period of exposure. In the resistant subline, MEB CD activity was higher than that of verapamil. Moreover; treatment of cells with MEBCD resulted in a modification in cell membrane integrity and cell morphology, but had no own activity in the distribution of t he cells within cell cyle.